Biomerica Inc (BMRA):企業の製品パイプライン分析

◆英語タイトル:Biomerica Inc (BMRA) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME1309PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose various diseases and medical complications. It focuses on the development of products for diabetes, gastrointestinal, food intolerances and esoteric tests by utilizing enzyme immunoassay technology. Biomerica’s diagnostic tests are used by hospitals, clinical laboratories, physician’s offices, and consumers around the world. The company distributes products in Americas, Europe, Asia and the Middle East. Biomerica is headquartered in Irvin, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biomerica Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Biomerica Inc Company Overview
Biomerica Inc Company Snapshot
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc – Pipeline Analysis Overview
Business Description
Biomerica Inc – Key Facts
Biomerica Inc – Major Products and Services
Biomerica Inc Pipeline Products by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Pipeline Products Overview
HP Detect H. Pylori Test
HP Detect H. Pylori Test Product Overview
InFoods – Crohn’s Disease
InFoods – Crohn’s Disease Product Overview
InFoods – Functional Dyspepsia
InFoods – Functional Dyspepsia Product Overview
InFoods – Gastroesophageal Reflux Disease
InFoods – Gastroesophageal Reflux Disease Product Overview
InFoods – Ulcerative Colitis
InFoods – Ulcerative Colitis Product Overview
InFoods IBS
InFoods IBS Product Overview
InFoods IBS Clinical Trial
Rapid IgG/IgM Test – COVID-19
Rapid IgG/IgM Test – COVID-19 Product Overview
Serological ELISA Test – COVID-19
Serological ELISA Test – COVID-19 Product Overview
Biomerica Inc – Key Competitors
Biomerica Inc – Key Employees
Biomerica Inc – Key Employee Biographies
Biomerica Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biomerica Inc, Recent Developments
Jan 07, 2020: Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods irritable bowel syndrome (IBS) diagnostic guided therapy clinical trial
Oct 16, 2019: Biomerica reports 1st quarter fiscal 2020 financials
Aug 30, 2019: Biomerica announces fiscal year end 2019 financial results
Aug 21, 2019: Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
Jun 05, 2019: Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million
Apr 16, 2019: Biomerica announces third quarter financial results
Apr 08, 2019: Biomerica announces Notice of Allowance for new U.S. Patent application covering diagnostic guided therapy for irritable bowel syndrome (IBS)
Feb 05, 2019: Biomerica announces updates for H. Pylori clinical studies
Jan 15, 2019: Biomerica announces second quarter financial results
Oct 16, 2018: Biomerica announces 1st Quarter Fiscal 2019 Financials
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Biomerica Inc Pipeline Products and Ongoing Clinical Trials Overview
Biomerica Inc Pipeline Products by Equipment Type
Biomerica Inc Pipeline Products by Indication
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc, Key Facts
Biomerica Inc, Major Products and Services
Biomerica Inc Number of Pipeline Products by Development Stage
Biomerica Inc Pipeline Products Summary by Development Stage
Biomerica Inc Ongoing Clinical Trials by Trial Status
Biomerica Inc Ongoing Clinical Trials Summary
HP Detect H. Pylori Test - Product Status
HP Detect H. Pylori Test - Product Description
InFoods - Crohn’s Disease - Product Status
InFoods - Crohn’s Disease - Product Description
InFoods - Functional Dyspepsia - Product Status
InFoods - Functional Dyspepsia - Product Description
InFoods - Gastroesophageal Reflux Disease - Product Status
InFoods - Gastroesophageal Reflux Disease - Product Description
InFoods - Ulcerative Colitis - Product Status
InFoods - Ulcerative Colitis - Product Description
InFoods IBS - Product Status
InFoods IBS - Product Description
InFoods IBS - Endpoint Determination Study for an Antibody Guided Dietary Restriction Trial Using Biomerica InFoods IBS Test in Patients with a Previous Diagnosis of Irritable Bowel Syndrome (IBS)
Rapid IgG/IgM Test - COVID-19 - Product Status
Rapid IgG/IgM Test - COVID-19 - Product Description
Serological ELISA Test - COVID-19 - Product Status
Serological ELISA Test - COVID-19 - Product Description
Biomerica Inc, Key Employees
Biomerica Inc, Key Employee Biographies
Biomerica Inc, Subsidiaries
Glossary

★海外企業調査レポート[Biomerica Inc (BMRA):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Venture Corporation Limited (V03):企業の財務・戦略的SWOT分析
    Venture Corporation Limited (V03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BBVA Banco Frances S.A. (FRAN3):企業の財務・戦略的SWOT分析
    BBVA Banco Frances S.A. (FRAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GenomeDx Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析
    Summary Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linea …
  • National Bank of Canada:企業のM&A・事業提携・投資動向
    National Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • China Environmental Energy Investment Limited:企業のM&A・事業提携・投資動向
    China Environmental Energy Investment Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Environmental Energy Investment Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Royal DSM N.V.:企業のM&A・事業提携・投資動向
    Royal DSM N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Royal DSM N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • J.K. Cement Ltd (JKCEMENT):企業の財務・戦略的SWOT分析
    J.K. Cement Ltd (JKCEMENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析
    Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lancaster Colony Corporation:企業の戦略・SWOT・財務情報
    Lancaster Colony Corporation - Strategy, SWOT and Corporate Finance Report Summary Lancaster Colony Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Air France-KLM SA:企業の戦略・SWOT・財務情報
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Cleanaway Waste Management Ltd (CWY):企業の財務・戦略的SWOT分析
    Summary Cleanaway Waste Management Ltd (Cleanaway), formerly Transpacific Industries Group Ltd, is a clean technology company that offers waste management and recycling services. The company's services include general waste cleaning and maintenance, industrial cleaning services, liquid and hazardous …
  • Arch Capital Group Ltd.:戦略・SWOT・企業財務分析
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Chubb Limited:企業の戦略・SWOT・財務情報
    Chubb Limited - Strategy, SWOT and Corporate Finance Report Summary Chubb Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • De Beers Group Plc:企業の戦略・SWOT・財務情報
    De Beers Group Plc - Strategy, SWOT and Corporate Finance Report Summary De Beers Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Mobile Limited:企業の戦略・SWOT・財務情報
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆